Orica Ltd:企業の戦略・SWOT・財務分析

◆英語タイトル:Orica Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5328
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Metals and Mining
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥44,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥67,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Orica Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Orica Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Orica Ltd (Orica) is a provider of commercial explosives and blasting systems to quarrying, oil and gas, mining and construction markets. The company supplies sodium cyanide for gold extraction and provides ground support services in mining and tunneling. Its blasting systems include bulk systems, initiating systems, electronic blasting systems and packaged explosives. Orica’s mining chemicals include emulsifiers, sparge and sodium cyanide. The company also manufactures and supplies anchoring products, bolts, cementitious grouts and coatings, injectable chemicals and foams, resin capsules, ballast bonding polymers pumps and accessories, accessories and engineering services through its subsidiary Minova. The company operates in Asia Pacific, North America, Latin America, Europe, the Middle East, and Africa. Orica is headquartered in Melbourne, New South Wales, Australia.

Scope

- Detailed information on Orica Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Orica Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Orica Ltd including a breakdown and examination of key business segments
- Intelligence on Orica Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Orica Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Orica Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Orica Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Orica Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Orica Ltd: Company Overview
Orica Ltd: Overview and Key Facts
Orica Ltd: Overview
Orica Ltd: Key Facts
Orica Ltd: Key Employees
Orica Ltd: Key Employee Biographies
Orica Ltd: Major Products and Services
Orica Ltd: Company History
Orica Ltd: Management Statement
Orica Ltd: Locations and Subsidiaries
Orica Ltd: Key Competitors
Orica Ltd: Company Analysis
Orica Ltd: Business Description
Orica Ltd: SWOT Analysis
Orica Ltd: SWOT Overview
Orica Ltd: Strengths
Orica Ltd: Weaknesses
Orica Ltd: Opportunities
Orica Ltd: Threats
Orica Ltd: Corporate Financial Deals Activity
Orica Ltd: Financial Deals Overview
Orica Ltd: Targets and Partners
Orica Ltd: Top Deals 2016 – 2020YTD*
Orica Ltd: Advisors
Orica Ltd: Top Legal Advisors
Orica Ltd: Top Financial Advisors
Orica Ltd: Mergers and Acquisitions
Orica Ltd: Capital Raising
Orica Ltd: Recent Developments
Orica Ltd: News and Events Summary
Orica Ltd: Business Expansion
Orica Ltd: Contracts
Orica Ltd: Corporate Governance
Orica Ltd: Financial Deals
Orica Ltd: Financial Performance
Orica Ltd: Market Developments
Orica Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Orica Ltd: Key Facts
Table 2: Orica Ltd: Key Employees
Table 3: Orica Ltd: Company History
Table 4: Orica Ltd: Locations and Subsidiaries
Table 5: Orica Ltd: Key Competitors
Table 6: Orica Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Orica Ltd: M&A Activity by Geography (TTM*)
Table 8: Orica Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Orica Ltd: M&A Average Deal Size - Value (US$m)
Table 10: Orica Ltd: Targets and Partners
Table 11: Orica Ltd: Top Deals 2016 - 2020YTD*
Table 12: Orica Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: Orica Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: Orica Ltd: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Orica Ltd: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Orica Ltd: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Orica Ltd: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Orica Ltd: News and Events Summary
Table 19: Orica Ltd: Business Expansion
Table 20: Orica Ltd: Contracts
Table 21: Orica Ltd: Corporate Governance
Table 22: Orica Ltd: Financial Deals
Table 23: Orica Ltd: Financial Performance
Table 24: Orica Ltd: Market Developments
Table 25: Orica Ltd: Strategy and Operations

★海外企業調査レポート[Orica Ltd:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AnaMar AB:製薬・医療:M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …
  • International Paper APPM Limited:企業の戦略・SWOT・財務情報
    International Paper APPM Limited - Strategy, SWOT and Corporate Finance Report Summary International Paper APPM Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Orascom Development Egypt Sae:企業の戦略・SWOT・財務分析
    Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report Summary Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Mapfre S.A. (MAP):企業の財務・戦略的SWOT分析
    Mapfre S.A. (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Royal FrieslandCampina N.V.:企業のM&A・事業提携・投資動向
    Royal FrieslandCampina N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal FrieslandCampina N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. ValiRx uses GeneICE technology, which enables silen …
  • Laboratorios SALVAT SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorios SALVAT SA (SALVAT) is a manufacturer of pharmaceutical products for healthcare industries. The company offers prescription and over-the- counter drugs in various segments such as personal healthcare, metabolism, urology, ophtholmology, dermatology and malaria. Its personal healt …
  • Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskB …
  • OPTIMA packaging group GmbH:戦略・SWOT・企業財務分析
    OPTIMA packaging group GmbH - Strategy, SWOT and Corporate Finance Report Summary OPTIMA packaging group GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MDNA Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • China Investment Corp:企業のM&A・事業提携・投資動向
    China Investment Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Investment Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Torrent Power Ltd (TORNTPOWER):電力:M&Aディール及び事業提携情報
    Summary Torrent Power Limited (Torrent Power), a subsidiary of Torrent Group is a power utility that generates, transmits and distributes electricity. The company generates electricity through coal based, gas based and renewable power plants. It distributes power to residential, commercial and indus …
  • Credit Du Nord Sa
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Plasticell Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Plasticell Ltd (Plasticell) is a biotechnology company that develops therapies derived from research using its combinatorial cell culture technology. The company offers therapeutic programs such as expansion of hematopoietic stem cells from bone marrow and cord blood, platelets and immune ce …
  • Innocoll AG:医療機器:M&Aディール及び事業提携情報
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product Xaracoll, a bupivacaine HC …
  • Assa Abloy AB:企業のM&A・事業提携・投資動向
    Assa Abloy AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Assa Abloy AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Matalan Retail Limited:企業の戦略・SWOT・財務情報
    Matalan Retail Limited - Strategy, SWOT and Corporate Finance Report Summary Matalan Retail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lee Memorial Health System:企業の戦略的SWOT分析
    Lee Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • UCL Business PLC:企業のM&A・事業提携・投資動向
    UCL Business PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCL Business PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆